NCT00353509View on ClinicalTrials.gov

Safety and Effectiveness Study of the Solysafe Septal Occluder

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Atrial Septal Defects
Interventions
DEVICE

Device Closure of a Septal Defect

Trial Locations (1)

11000

University Childen's Hospital, Belgrade

All Listed Sponsors
lead

Carag AG

INDUSTRY

NCT00353509 - Safety and Effectiveness Study of the Solysafe Septal Occluder | Biotech Hunter | Biotech Hunter